SECURITIES MARKET INFORMATION BULLETIN 01/12/2022
The 17,027,010 rights (LAVIR) of the company "LAVIPHARM S.A." are admitted to trading on the ATHEX, following the recent share capital increase carried out in the form of a rights issue. The pre-emption right's trading period is set from December 1, 2022 to December 9, 2022, included. The start price is set at €0.0800 for LAVIR. The ISIN Code is GRX246003024. There is no daily ceiling/floor limit for the rights' trading. The pre-emption right's subscription period is set from December 1, 2022, to December 14, 2022, included.
New Listings Prospectuses
Laws and Regulations
|44 34 18 57|